Lane; David Philip
Patent Applications and Registrations
Patent applications and USPTO patent grants for Lane; David Philip.The latest application filed is for "mab 2 anti-met antibody".
- Lane; David Philip - Singapore SG
- Lane; David Philip - Fife N/A GB
- Lane; David Philip - St. Andrews GB
- Lane; David PHilip - Dundee GB
| Patent | Date |
|---|---|
| mAB 2 anti-Met antibody Grant 9,994,644 - Wong , et al. June 12, 2 | 2018-06-12 |
| Aroyl thiourea derivatives Grant 9,365,508 - Lain , et al. June 14, 2 | 2016-06-14 |
| Mab 2 Anti-met Antibody App 20160083479 - Wong; Shuxian Julin ; et al. | 2016-03-24 |
| STAPLING eIF4E INTERACTING PEPTIDES App 20160046672 - Brown; Christopher John ; et al. | 2016-02-18 |
| Methods For Determining Resistance Against Molecules Targeting Proteins App 20150276755 - Ghadessy; Farid ; et al. | 2015-10-01 |
| Compounds App 20120149778 - Lain; Sonia ; et al. | 2012-06-14 |
| Methods and Means For Inhibition of CDK4 Activity App 20080249025 - Ball; Kathryn Lindsay ; et al. | 2008-10-09 |
| Use of peptides Grant 7,141,541 - Proud , et al. November 28, 2 | 2006-11-28 |
| Inhibitors of the interaction between P53 and MDM2 Grant 7,083,983 - Lane , et al. August 1, 2 | 2006-08-01 |
| Methods and means for inhibition of Cdk4 activity Grant 6,962,792 - Ball , et al. November 8, 2 | 2005-11-08 |
| Methods of treatment of chronic lymphocytic leukemia using roscovitine App 20050153991 - Gianella-Borradori, Athos ; et al. | 2005-07-14 |
| Inhibitors of the Interaction between p53 and MDM2 App 20050137137 - Lane, David Philip ; et al. | 2005-06-23 |
| Methods and means for inhibition of CDK4 activity App 20040214765 - Ball, Kathryn Lindsay ; et al. | 2004-10-28 |
| Novel p53 inducible protein App 20040146971 - Lane, David Philip ; et al. | 2004-07-29 |
| Cyclin dependent kinase binding compounds App 20040029791 - Fahraeus, Robin ; et al. | 2004-02-12 |
| Interruption of binding of MDM2 and P53 protein and therapeutic application thereof Grant 6,153,391 - Picksley , et al. November 28, 2 | 2000-11-28 |
| Interruption of binding of MDM2 and P53 protein and therapeutic application thereof Grant 5,770,377 - Picksley , et al. June 23, 1 | 1998-06-23 |
| Interruption of binding of MDM2 and p53 protein and therapeutic application thereof Grant 5,702,908 - Picksley , et al. December 30, 1 | 1997-12-30 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 